Clinical Trial Details

Overview

Research Study Summary

Premature Ejaculation

Purpose

Double-Blind, Placebo Controlled, Parallel Group study to evaluate the effect of three different doses of XXXX on intravaginal ejaculatory latency time and patient reported outcomes in men with lifelong premature ejaculation

To Learn more

CW ID: 224166
Date Last Changed: April 18, 2017

Clinical Trial Snapshot

Phase
2
Gender
Male
Age
18 to 60 Years
Overall Status
Recruiting
Lead Sponsor
Ixchelsis
Duration
10 Weeks
Facility Type
Out-Patient

Eligibility

  • Healthy Men age 18 to 60 years
  • Have rapid ejaculation throughout adult life
  • Be in a steady heterosexual relationship for at least 6 months
  • Not be planning pregnancy with partner
  • Not have erectile dysfunction
  • More Info

    For more information, please contact:
    South Florida Medical Research
    305-931-8080 ext. 306

    Contact

    Cheryl Ahlstrom, Patient Liaison
    South Florida Medical Research
    21150 Biscayne Blvd. Suite #300
    Aventura, FL 33180
    Phone: 305-931-8080 ext. 306
    Fax: 305-931-8088

    View Map

    Research Center Information:

    South Florida Medical Research

    Volunteer for this Trial

    If you would like to learn more about participating in this research study, please email the trial contact using the form below. We value your privacy and your information will only be used by the research center to contact you regarding this study.

    DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.